Phase II Trial of Primary Systemic Therapy for Locally Advanced Breast Cancer Using Sequential Doxil, Paclitaxel, and Cyclophosphamide With Concurrent Avastin
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Bevacizumab; Cyclophosphamide; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 May 2016 Status changed from active, no longer recruiting to completed.
- 01 Jul 2014 Planned End Date changed from 1 Aug 2017 to 1 Jun 2019 as reported by ClinicalTrials.gov record.
- 15 Jun 2012 Planned end date changed from 1 Oct 2012 to 1 Aug 2017 as reported by ClinicalTrials.gov.